secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aspire Biopharma Holdings, Inc. (ASBP)
CIK:        0001847345
Form:       8-K
Filed at:   2024-10-10T23:59:59+00:00
Accession:  0001493152-24-040725
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PowerUp extends Aspire merger disclosure schedule delivery to Oct 11, 2024
--------------------------------------------------------------------------

- Second Amendment Agreement moves Disclosure Schedule Delivery Date to October 11, 2024.
- Allows additional time for due diligence and compilation of disclosure schedules.
- No changes to merger consideration, equity incentive pool, or other key terms.
- Amendment is in connection with the previously announced business combination with Aspire Biopharma.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1847345/000149315224040725/0001493152-24-040725-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1847345/000149315224040725/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-040725

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer